LEXX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lexaria Bioscience Corp

Watchlist Manager

Watchlist

Price: 0.6105 USD 3.65% Market Closed

Market Cap: $15.1m

	Lexaria Bioscience Corp NASDAQ:LEXX	CA
	Alight Inc NYSE:ALIT	US
	Spearmint Resources Inc F:SQH	CA
U	Universal Health Realty Income Trust F:WY8	US
T	Teradata Corp SWB:3T4	US
	XORTX Therapeutics Inc F:ANUA	CA
	Cochlear Ltd ASX:COH	AU
K	Koppers Holdings Inc XBER:KO9	US
M	Mawson Gold Ltd SWB:MXR	CA
T	Teradata Corp XBER:3T4	US
	GR Engineering Services Ltd ASX:GNG	AU
	Sats ASA F:2S0	NO

Profitability Summary

Lexaria Bioscience Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

79% > 100%

Negative Operating Margin

-2 572%

Negative 3Y Average Operating Margin

-1 865%

Declining Operating Margin

-2 050% > -2 572%

Negative Net Margin

-2 590%

Negative 3Y Average Net Margin

-1 872%

Declining Net Margin

-2 029% > -2 590%

Negative Free Cash Flow Margin

-2 612%

Negative 3Y Average Free Cash Flow Margin

-1 702%

Declining Free Cash Flow Margin

-1 644% > -2 612%

Negative ROE

-139%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-659%

Declining ROIC

-553% > -929%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.